MG

Mukesh Govindbhai Dorara

Active Director Director DIN 09081651
DIN 09081651 First appointment Feb 2021 Primary industry FMCG
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Mukesh Govindbhai Dorara

Data last updated:

Mukesh Govindbhai Dorara is a Director at Dermakrom Healthcare Private Limited (since 2021). The company operates in FMCG.

DIN 09081651
Primary Designation Director
Industry FMCG
First Appointment 25 Feb 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dermakrom Healthcare Private Limited U24290GJ2021PTC120617
Director25 Feb 20212021Active

Board colleagues of Mukesh Govindbhai Dorara

Directorship timeline

Open interactive timeline →
Dermakrom Healthcare Private Limited
Premium access

Shareholding and investment profile for Mukesh Govindbhai Dorara

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mukesh Govindbhai Dorara

Mukesh Govindbhai Dorara currently holds 1 directorship: Dermakrom Healthcare Private Limited (Director, since 25 Feb 2021).

Mukesh Govindbhai Dorara was first appointed on 25 Feb 2021 as Director at Dermakrom Healthcare Private Limited.

The current boards of Mukesh Govindbhai Dorara's companies include Jigar Ashokbhai Dave (Dermakrom Healthcare Private Limited), Komal Singh Sisodiya (Dermakrom Healthcare Private Limited), Raman Singh Tomar (Dermakrom Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available